Published in

Wiley, Acta Neurologica Scandinavica, 2(130), p. 81-89, 2014

DOI: 10.1111/ane.12239

Links

Tools

Export citation

Search in Google Scholar

Assessing tissue damage in multiple sclerosis: a biomarker approach.

Journal article published in 2014 by J. Burman ORCID, H. Zetterberg, M. Fransson, As S.-I. Loskog, R. Raininko, J. Fagius
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Magnetic resonance imaging (MRI) of the brain and spinal cord is the gold standard for assessing disease activity in multiple sclerosis (MS). MRI is an excellent instrument for determination of accumulated damage to the brain and spinal cord, but tells us little about ongoing tissue damage. In this study, biomarkers of oligodendrocyte, axonal and astrocyte injury were related to MRI and clinical findings and used to assess tissue damage in MS.